Cantor Fitzgerald Reiterates Overweight on Eli Lilly and Co, Maintains $885 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen reiterates an Overweight rating on Eli Lilly and Co (NYSE:LLY) and maintains a $885 price target.
July 01, 2024 | 3:12 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Eli Lilly and Co (NYSE:LLY) and maintained a $885 price target.
The reiteration of an Overweight rating and a high price target of $885 by a reputable analyst is likely to positively impact investor sentiment and could lead to a short-term increase in Eli Lilly's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100